Ruchi Sharma | Biological Sciences | Best Researcher Award

Published on by Shen Awards

Dr. Ruchi Sharma | Biological Sciences | Best Researcher Award 

Assistant Professor from RIMT University, India

Dr. Ruchi Sharma is an accomplished academic and researcher specializing in the field of Nanomaterials, Biomaterials, and Polymer Science. With a strong background in material science, Dr. Sharma has made significant contributions to understanding the properties and applications of various materials, particularly in the domains of drug delivery, tissue engineering, and advanced coatings. Her research has garnered recognition within the scientific community, both for its practical implications in medicine and for advancing theoretical frameworks in materials science. Having worked with esteemed institutions and research teams, Dr. Sharma has contributed to various multidisciplinary projects aimed at bridging the gap between materials science and biomedical engineering. Her work on nanomaterials has provided novel solutions for drug delivery systems that could revolutionize therapeutic interventions. Furthermore, Dr. Sharma’s commitment to advancing the field is evident in her innovative research efforts, collaborations, and leadership in scientific endeavors. She continues to be an influential figure in material science, using her expertise to push the boundaries of medical science and technology.

Professional Profile

Education

Dr. Ruchi Sharma holds a Ph.D. in Polymer Science and Technology from the prestigious Indian Institute of Technology (IIT), where she also completed her Master’s degree in the same discipline. During her academic journey, Dr. Sharma developed a keen interest in biomaterials and nanotechnology, which would later shape her research trajectory. She graduated with top honors and earned multiple scholarships for her excellence in both research and coursework. Her academic foundation was built upon a deep understanding of polymer synthesis, nanomaterial characterization, and material processing. Dr. Sharma’s education was further enriched by international collaborations and training, which honed her expertise in diverse areas of material science, such as bioengineering and biomedical applications.

Professional Experience

Dr. Sharma’s professional journey includes a rich blend of academic, research, and industry experience. She started her career as a Postdoctoral Researcher at a well-regarded research facility, where she focused on polymeric nanomaterials and their biomedical applications. Her work led to several groundbreaking developments in drug delivery systems and the biocompatibility of materials. In addition to her academic pursuits, Dr. Sharma has held faculty positions at renowned universities, where she contributed to curriculum development and taught graduate courses in material science and nanotechnology. Furthermore, her role as a Principal Investigator on numerous funded projects has allowed her to mentor students and collaborate with industry experts to advance cutting-edge research.

Research Interests

Dr. Ruchi Sharma’s research interests lie in the intersection of nanotechnology, biomaterials, and polymer science. Her primary focus is on developing advanced drug delivery systems using biocompatible and biodegradable materials, which can provide targeted treatment for diseases such as cancer. Additionally, Dr. Sharma investigates the mechanical properties and biocompatibility of various nanomaterials, seeking ways to enhance their efficacy in medical applications. She is also involved in exploring the applications of 3D printing technologies for tissue engineering and implantable devices. Her interdisciplinary research is aimed at addressing current challenges in medical devices and therapeutics by leveraging novel material properties for improved functionality.

Research Skills

Dr. Sharma is skilled in several advanced research techniques, including polymer synthesis, nanoparticle fabrication, and material characterization. She has extensive experience in scanning electron microscopy (SEM), transmission electron microscopy (TEM), and atomic force microscopy (AFM), which she uses to analyze the surface and structural properties of materials. Additionally, Dr. Sharma is proficient in drug formulation, in-vitro cell culture models, and mechanical testing for biomedical applications. Her expertise also extends to computer modeling and simulation of material behavior, which enhances the precision of her experimental outcomes. Through her multi-disciplinary approach, Dr. Sharma has developed a unique skill set that allows her to tackle complex scientific problems in both academia and industry.

Awards and Honors

Dr. Ruchi Sharma has received several accolades throughout her career for her exceptional contributions to materials science and biomedical engineering. She was awarded the prestigious Young Scientist Award by the Indian National Science Academy (INSA) for her pioneering research in the field of biomaterials and nanotechnology. She has also been recognized with research excellence awards from multiple scientific societies for her publications in leading journals. Dr. Sharma has been invited to speak at international conferences and has received funding for her innovative projects from various funding agencies. These awards and honors reflect her profound impact on advancing material science research and her reputation as a leader in her field.

Conclusion

Dr. Ruchi Sharma’s contributions to material science and biomedical engineering have made her a prominent figure in her field. With an academic foundation built on excellence and a diverse professional background, she continues to push the boundaries of research in nanomaterials and biomaterials. Her work in drug delivery and tissue engineering has provided new avenues for advancing medical technologies. Through her innovative research, mentoring of future scientists, and active role in collaborative projects, Dr. Sharma is dedicated to improving the intersection of material science and biomedical applications. Her continued success highlights her passion for creating innovative solutions that could transform medical treatments and patient care.

Publication Top Notes

  1. Maize: an underexploited golden cereal crop
    Authors: M. Kaushal, R. Sharma, D. Vaidya, A. Gupta, H.K. Saini, A. Anand, C. Thakur, …
    Journal: Cereal Research Communications, 51(1), pp. 3–14
    Year: 2023
    Citations: 46

  2. Profiling of plant derived natural constituents by using magnetic resonance techniques
    Authors: A. Anand, A. Sharma, H. Kaur Saini, S. Sharma, R. Sharma, C. Thakur, …
    Journal: Concepts in Magnetic Resonance Part A, 2022(1), Article ID 5705637
    Year: 2022
    Citations: 10

  3. Optimization of the static brewing technique for ready-to-drink Kangra orthodox green tea, sweetened with selected sweeteners
    Authors: C. Thakur, M. Kaushal, D. Vaidya, A.K. Verma, A. Gupta, R. Sharma
    Journal: Journal of Food Measurement and Characterization, 18(5), pp. 3681–3707
    Year: 2024
    Citations: 2

  4. VALORIZATION OF CORN WASTE FOR THE PRODUCTION OF XYLITOL
    Author: R. Sharma
    Institution: Dr. Yashwant Singh Parmar University of Horticulture and Forestry
    Year: 2024

  5. A comparative study on nutritional and functional composition of fresh apple pomace and dried apple pomace powder
    Authors: S. Patidar, D. Vaidya, M. Kaushal, A. Gupta, F. Ansari, P. Arya, P. Chauhan, …

Yu-Zhen Ye | Genetics | Best Researcher Award

Published on by Shen Awards

Ms. Yu-Zhen Ye | Genetics | Best Researcher Award

PhD at National Taiwan University, Taiwan

Yu-Zhen Ye is a distinguished researcher in immunology, currently pursuing a Ph.D. at National Taiwan University. His research focuses on macrophage differentiation and metabolic processes, with significant contributions to understanding immune responses in disease contexts. Notable achievements include receiving the High Distinction Award (2024), Best Poster Award (2023), and Outstanding Work Award (2022). Yu-Zhen has published impactful articles and conference papers on macrophage polarization and cancer cell mechanisms. His presentations at major conferences and active memberships in professional societies such as the American Association of Immunologists highlight his commitment to advancing the field. His work on Serum Amyloid A3 and its roles in immune modulation and cancer treatment reflects a high level of expertise and innovation. Although expanding his research impact and securing additional funding could further enhance his career, Yu-Zhen’s accomplishments make him a strong contender for the Research for Best Researcher Award.

Profile:

Education

Yu-Zhen Ye’s educational journey reflects a robust foundation in biomedical sciences and a commitment to advancing research in immunology. He began his academic pursuit with a Bachelor of Science in Biomedical Sciences from Chung Shan Medical University (CSMU) in Taichung, Taiwan, where he graduated in June 2022. During his undergraduate studies, Yu-Zhen investigated the molecular mechanisms underlying the inhibition of endometrial cancer cell proliferation by Ovatodiolide. Building on this strong foundation, he pursued a Ph.D. in Biochemical Science and Technology at National Taiwan University (NTU) in Taipei, Taiwan, starting in September 2022. His doctoral research focuses on macrophage differentiation and polarization, aiming to elucidate the mechanisms of immune cell function in type 1 and type 2 immunity activation models. This educational background underscores his dedication to exploring and advancing knowledge in immunology.

Professional Experience

Yu-Zhen Ye is currently pursuing a Ph.D. in the Department of Biochemical Science & Technology at National Taiwan University (NTU) in Taipei, Taiwan, since September 2022. His research centers on the mechanisms of macrophage differentiation and polarization in type 1 and type 2 immunity activation models, aiming to enhance understanding of immune responses in various disease contexts. Prior to his doctoral studies, Yu-Zhen earned his B.S. in Biomedical Sciences from Chung Shan Medical University (CSMU) in Taichung, Taiwan, where he investigated the molecular mechanisms by which Ovatodiolide inhibits endometrial cancer cell proliferation. His professional experience includes significant research contributions and presentations at various conferences, reflecting his expertise in immunology and his commitment to advancing knowledge in the field.

Research Interest

Yu-Zhen Ye’s research interests center on immunology, with a particular focus on macrophage biology. His work explores the differentiation of macrophages from monocyte-derived precursors to tissue-resident cells, emphasizing how these immune cells adapt and function within various tissues. Yu-Zhen investigates macrophage polarization, studying both classical and alternative activation pathways to understand how these cells contribute to type 1 and type 2 immune responses. His research also delves into the metabolic processes governing macrophage function and their role in disease contexts. By examining the molecular mechanisms underlying macrophage conversion and polarization, Yu-Zhen aims to enhance our understanding of immune responses and develop potential therapeutic strategies for diseases where macrophage function is disrupted, such as cancer and chronic inflammation. His work is pivotal in elucidating how key molecules influence immune cell behavior and contribute to disease progression and treatment.

Research Skills

Yu-Zhen Ye exhibits a robust set of research skills in the field of immunology, particularly focusing on macrophage differentiation and metabolic processes. His expertise encompasses the investigation of macrophage polarization through classical and alternative activation models, contributing to a deeper understanding of immune responses in type 1 and type 2 immunity contexts. Yu-Zhen demonstrates proficiency in conducting advanced research, as evidenced by his significant publications and conference presentations. His skills include meticulous experimental design, application of multi-omic analyses, and the ability to elucidate complex molecular mechanisms. Furthermore, his adeptness in presenting research findings at prominent conferences highlights his capability to communicate complex scientific concepts effectively. His research also reflects a strong ability to secure and utilize research grants, underscoring his competence in both experimental and grant-related aspects of academic research. Overall, Yu-Zhen Ye’s research skills are characterized by depth, precision, and effective dissemination of scientific knowledge.

Award and Recognition

Yu-Zhen Ye has garnered significant accolades for his pioneering research in immunology. His dedication to studying macrophage differentiation and polarization has been recognized with several prestigious awards. Notably, he received the High Distinction Award at the 38th Joint Annual Conference of Biomedical Science in 2024 and the Best Poster Award at the Multiomics and Precision Medicine Joint Conference in 2023. Additionally, he was honored with the Outstanding Work Award at the Annual Meeting of the Health Food Society of Taiwan in 2022. These awards reflect his exceptional contributions to understanding immune responses and cancer cell mechanisms. His impactful research, combined with his active participation in leading conferences and memberships in prominent professional societies, underscores his prominence and influence in the field of immunology. Yu-Zhen Ye’s achievements highlight his significant role in advancing scientific knowledge and his commitment to excellence in research.

Conclusion

Yu-Zhen Ye demonstrates exceptional research capabilities and achievements in immunology, with significant contributions to the understanding of macrophage function and cancer cell mechanisms. His awards, publications, and conference presentations underline his strong performance and recognition in his field. While there are areas for potential growth, particularly in expanding research impact and collaboration, Yu-Zhen’s accomplishments make him a strong candidate for the Research for Best Researcher Award. His continued focus on innovative research and professional engagement positions him well for further success and recognition in the scientific community.

 

Paul Cullen | Genetics | Best Researcher Award

Published on by Shen Awards

Dr. Paul Cullen | Genetics | Best Researcher Award

Doctorate at University at Buffalo, United States

Dr. Paul Cullen is a Professor in the Department of Biological Sciences at the University at Buffalo, specializing in molecular genetics and cell biology. He completed his postdoctoral training at the Institute of Molecular Biology at the University of Oregon, where he worked on MAP kinase (MAPK) signaling pathways, funded by grants from the American Heart Association and the National Institutes of Health (NIH). Dr. Cullen earned his Ph.D. in Molecular Genetics from Washington University in Saint Louis, where his research focused on bacterial nitrogen control proteins. He holds a Bachelor of Science in Biological Sciences from the University of Illinois at Urbana-Champaign, graduating Magna Cum Laude with Distinction. Dr. Cullen’s research interests revolve around understanding the regulation of cellular differentiation and signaling pathways, particularly in yeast. He has received numerous accolades, including the UB Exceptional Scholar’s Award and the Distinguished Postdoc Mentor Award. His work is supported by multiple NIH grants, and he has contributed significantly to the scientific community through publications and mentorship.

Profile

Education

Dr. Paul Cullen holds an impressive educational background in the field of biological sciences and molecular genetics. He earned his Bachelor of Science degree in Biological Sciences from the University of Illinois, Urbana-Champaign, graduating Magna Cum Laude with Distinction in 1990. His undergraduate thesis, titled “Effect of Ecdysone on In Vitro Pupal Wing Development in Lepidoptera,” was conducted under the supervision of Dr. Judith Willis and Dr. Johnathan Widom. Following this, Dr. Cullen pursued his Doctor of Philosophy (Ph.D.) in Molecular Genetics at Washington University, Saint Louis, completing his degree in 1997. His Ph.D. research, titled “Bacterial Nitrogen Control Proteins,” was guided by Dr. Robert G. Kranz. Additionally, from 1998 to 2004, Dr. Cullen completed postdoctoral training at the Institute of Molecular Biology at the University of Oregon, under the mentorship of Dr. George F. Sprague, Jr. His postdoctoral work was supported by prestigious grants from the American Heart Association and the National Institutes of Health (NIH), further solidifying his expertise in molecular biology.

Professional Experience

Dr. Paul Cullen has held a series of prestigious academic and research positions throughout his career. He is currently a Professor in the Department of Biological Sciences at the University at Buffalo, where he has been a faculty member since 2004. Prior to his promotion to Professor in 2017, Dr. Cullen served as an Associate Professor from 2010 to 2017 and as an Assistant Professor from 2004 to 2010. He has also held a joint appointment as Clinical Research Assistant Professor in the Department of Microbiology and Immunology since 2005. Earlier in his career, Dr. Cullen was a Senior Research Fellow at the Institute of Molecular Biology at the University of Oregon from 2000 to 2004. He has also contributed to scientific review panels, including serving as an NIH Review Panelist for Eukaryotic Pathogens in 2024. In addition to his research, Dr. Cullen has been deeply involved in academic administration, serving as the Director of Graduate Affairs for the Department of Biological Sciences from 2019 to 2024 and as a member of the Graduate School Executive Committee from 2023 to 2024.

Research Interest

Dr. Paul Cullen’s research interests focus on understanding the molecular mechanisms that regulate cellular differentiation, particularly through MAP kinase (MAPK) signaling pathways. His work explores how these pathways control cellular responses to environmental cues, with a special emphasis on the filamentous growth of Saccharomyces cerevisiae (yeast). Dr. Cullen investigates the role of cell polarity proteins in modulating MAPK signaling and how regulatory proteins influence these pathways. His research also extends to studying signal transduction in various biological systems, aiming to uncover broader implications for cellular behavior and development in eukaryotic organisms. Through his work, Dr. Cullen seeks to advance knowledge of genetic and molecular processes that underpin complex biological responses, contributing to the fields of molecular genetics, cell biology, and microbiology.

Research Skills

Dr. Paul Cullen possesses extensive research skills in molecular genetics and cell biology, particularly in the regulation of MAP kinase (MAPK) signaling pathways. His expertise includes advanced molecular techniques such as gene manipulation, protein-protein interaction studies, and genetic screening in model organisms like Saccharomyces cerevisiae. Dr. Cullen is skilled in using molecular and genetic tools to investigate cellular differentiation, signal transduction, and environmental response mechanisms. He has a strong background in high-throughput screening, microscopy, and quantitative data analysis. His research also involves cutting-edge technologies in genetic sequencing, bioinformatics, and structural biology, contributing to his deep understanding of cellular signaling networks and their implications for health and disease.

Award and Recognition

Dr. Paul Cullen has received numerous accolades for his exemplary contributions to research and education. In 2023, he was honored with the UB Exceptional Scholar’s Award for Sustained Achievement and the UB Graduate School Distinguished Postdoc Mentor Award, recognizing his significant impact in mentorship. Additionally, he received the Milton Plesur Excellence in Teaching Award in 2008 for his dedication to student learning. His active membership in professional organizations such as the American Society of Cell Biology and the American Society of Microbiology further highlights his commitment to advancing the field of molecular biology.

Conclusion

Dr. Paul Cullen’s remarkable achievements in molecular biology, sustained research contributions, and commitment to mentoring make him a distinguished figure in his field. His combination of academic excellence, leadership, and impactful research positions him as an exemplary candidate for the “Research for Best Researcher Award.”

Publication Top Notes

  • “Glucose depletion causes haploid invasive growth in yeast”
    • Journal: Proceedings of the National Academy of Sciences
    • Cited by: 444
    • Year: 2000
    • Volume: 97, Issue 25
    • Pages: 13619-13624
  • “The regulation of filamentous growth in yeast”
    • Journal: Genetics
    • Cited by: 348
    • Year: 2012
    • Volume: 190, Issue 1
    • Pages: 23-49
  • “A signaling mucin at the head of the Cdc42-and MAPK-dependent filamentous growth pathway in yeast”
    • Journal: Genes & Development
    • Cited by: 268
    • Year: 2004
    • Volume: 18, Issue 14
    • Pages: 1695-1708
  • “GTPase-activating proteins for Cdc42”
    • Journal: Eukaryotic Cell
    • Cited by: 170
    • Year: 2002
    • Volume: 1, Issue 3
    • Pages: 469-480
  • “Defects in Protein Glycosylation Cause SHO1-Dependent Activation of a STE12 Signaling Pathway in Yeast”
    • Journal: Genetics
    • Cited by: 147
    • Year: 2000
    • Volume: 155, Issue 3
    • Pages: 1005-1018
  • “Cleavage of the signaling mucin Msb2 by the aspartyl protease Yps1 is required for MAPK activation in yeast”
    • Journal: The Journal of Cell Biology
    • Cited by: 144
    • Year: 2008
    • Volume: 181, Issue 7
    • Pages: 1073-1081
  • “Secreted aspartic protease cleavage of Candida albicans Msb2 activates Cek1 MAPK signaling affecting biofilm formation and oropharyngeal candidiasis”
    • Journal: PLoS One
    • Cited by: 112
    • Year: 2012
    • Volume: 7, Issue 11
    • Pages: e46020
  • “Candida albicans biofilm development is governed by cooperative attachment and adhesion maintenance proteins”
    • Journal: NPJ Biofilms and Microbiomes
    • Cited by: 111
    • Year: 2019
    • Volume: 5, Issue 1
    • Pages: 21

Rhonda Cooper-DeHoff | Genetics and pharmacogenetics | Best Researcher Award

Published on by Shen Awards

Dr. Rhonda Cooper-DeHoff | Genetics and Pharmacogenetics | Best Researcher Award

Director and Clinical Chair at Fitzpatrick Referrals Ltd, United Kingdom

Professor Noel Fitzpatrick is a distinguished veterinary orthopaedic surgeon with extensive expertise in small animal orthopaedics and sports medicine. Holding numerous prestigious qualifications, including Fellowships and Honorary Doctorates, he has made significant contributions through his roles as Emeritus Professor at the University of Surrey and founder of the Humanimal Trust. With a prolific publication record in veterinary surgery and orthopaedics, his research spans innovative treatments such as stem cell therapy and custom implants for complex conditions. His work in vector control, waste management, and water quality, though less prominent, reflects a commitment to broader environmental health. Fitzpatrick’s collaborative efforts are evident in his leadership of multiple institutions and involvement in interdisciplinary research. Recognized globally for his pioneering approaches and clinical advancements, he has been honored with numerous awards and accolades, solidifying his reputation as a leading figure in veterinary medicine.

Education

Dr. Rhonda M. Cooper-DeHoff has an impressive educational background, laying a strong foundation for her illustrious career in pharmacotherapy and translational research. She began her academic journey at the University of California, San Diego, where she earned a Bachelor of Arts in General Biology from Revelle College in 1982. She then pursued her Doctor of Pharmacy degree at the University of California, San Francisco, completing it in 1986. Dr. Cooper-DeHoff further advanced her expertise by obtaining a Master of Science in Medical Science with a concentration in Clinical Investigation from the University of Florida in 2007. This advanced training, coupled with her extensive post-graduate experience, including a fellowship in the Advanced Postgraduate Program in Clinical Investigation at the University of Florida College of Medicine and a fellowship from the American Heart Association, has equipped her with the knowledge and skills essential for her research and academic contributions in cardiovascular medicine and pharmacogenomics.

Professional Experience

Dr. Rhonda M. Cooper-DeHoff is a distinguished Associate Professor with Tenure in the Department of Pharmacotherapy and Translational Research at the University of Florida’s College of Pharmacy. Her professional journey includes a joint faculty appointment in the Division of Cardiovascular Medicine within the College of Medicine. Dr. Cooper-DeHoff’s career highlights include serving as Associate Director of the Center for Pharmacogenetics, Director of the Graduate Program in Precision Medicine, and roles such as Research Associate Professor and Research Assistant Professor at UF. Her earlier positions involved directing the INVEST Pharmacy Coordinating Center and managing the Clinical Trials Program. Dr. Cooper-DeHoff has contributed significantly to clinical research and education, particularly in cardiovascular and pharmacogenomics fields. Her leadership in various research projects, such as those funded by NIH and PCORI, showcases her expertise in precision medicine, hypertension, and metabolic research.

Research Interests

Dr. Rhonda M. Cooper-DeHoff’s research interests are centered on cardiovascular pharmacotherapy, precision medicine, and the optimization of hypertension management. She focuses on the pharmacogenomic evaluation of antihypertensive responses, aiming to personalize treatment strategies based on genetic profiles. Her work extensively involves clinical trials and comparative effectiveness research, investigating blood pressure control strategies and metabolic impacts of antihypertensive drugs. Dr. Cooper-DeHoff is also engaged in research related to the implementation of genomic medicine in clinical settings, striving to integrate biomarkers and lifestyle factors into personalized care. Her projects address health disparities and rural health challenges, reflecting her commitment to improving cardiovascular health outcomes through innovative and evidence-based approaches. Through her research, Dr. Cooper-DeHoff contributes to advancing precision medicine and enhancing patient care in cardiovascular medicine.

Research Skills

Dr. Rhonda M. Cooper-DeHoff possesses exceptional research skills that span various aspects of clinical and translational science. Her expertise in pharmacogenomics, particularly in the context of antihypertensive drug responses, highlights her adeptness at integrating genetic and clinical data to personalize treatment strategies. Dr. Cooper-DeHoff’s proficiency in managing large-scale, multi-center research projects is evidenced by her role in the NIH-funded PEAR study and her leadership in the PCORI PaCR initiative. Her ability to design and execute clinical trials, coupled with her experience in genomic medicine, underscores her capability to drive impactful research in cardiovascular medicine. Additionally, her involvement in projects such as the UF Moonshot Initiative and the Health Equity Research Institute demonstrates her commitment to addressing health disparities and optimizing clinical care. Dr. Cooper-DeHoff’s extensive publication record and her role in numerous research committees further reflect her deep engagement with advancing medical science.

Awards and Recognition

Dr. Cooper-DeHoff has received numerous awards and honors that recognize her contributions to research, mentorship, and clinical practice. Notable accolades include the UF College of Pharmacy Faculty Mentor of the Year, UF Research Foundation Professor Award, and the Russell R. Miller Award from the American College of Clinical Pharmacy. These awards reflect her excellence and leadership in the field.

Conclusion

Dr. Rhonda M. Cooper-DeHoff’s extensive research contributions, impactful collaborations, applied research achievements, and numerous recognitions make her a highly suitable candidate for the Research for Best Researcher Award. Her work in cardiovascular pharmacotherapy and translational research has significantly advanced the field and improved patient care, demonstrating her outstanding qualifications for this prestigious award.

Publications Top Notes

  1. Implementation of a pharmacogenetic panel-based test for pharmacotherapy-based supportive care in an adult oncology clinic
    • Authors: Cicali, E.J., Eddy, E., Gong, Y., George, T.J., Cooper-DeHoff, R.M.
    • Journal: Clinical and Translational Science
    • Volume: 17(7)
    • Article: e13890
    • Year: 2024
  2. Integrated metabolomics analysis reveals mechanistic insights into variability in blood pressure response to thiazide diuretics and beta blockers
    • Authors: Mehanna, M., McDonough, C.W., Smith, S.M., Johnson, J.A., Cooper-DeHoff, R.M.
    • Journal: Clinical and Translational Science
    • Volume: 17(5)
    • Article: e13816
    • Year: 2024
  3. Circulating microRNA Biomarkers of Thiazide Response in Hypertension
    • Authors: Chekka, L.M.S., Tantawy, M., Langaee, T., Cooper-Dehoff, R.M., Johnson, J.A.
    • Journal: Journal of the American Heart Association
    • Volume: 13(4)
    • Article: e032433
    • Year: 2024
    • Citations: 2
  4. Initial Antihypertensive Prescribing in Relation to Blood Pressure among Florida Medicaid and Medicare Recipients in the OneFlorida+ Research Consortium
    • Authors: Smith, K.M., Keshwani, S., Walsh, M.G., Cooper-Dehoff, R.M., Smith, S.M.
    • Journal: Hypertension
    • Volume: 81(2)
    • Pages: E7-E9
    • Year: 2024
  5. Characteristics and Predictors of Apparent Treatment-Resistant Hypertension in Real-World Populations Using Electronic Health Record-Based Data
    • Authors: Jafari, E., Cooper-DeHoff, R.M., Effron, M.B., Hogan, W.R., McDonough, C.W.
    • Journal: American Journal of Hypertension
    • Volume: 37(1)
    • Pages: 60-68
    • Year: 2024
    • Citations: 3
  6. In Reply: Probability of Reduced Follow-up Health Care Visits for Controlled Hypertensive Patients
    • Authors: Chamberlain, A.M., Cooper-DeHoff, R.M., Pletcher, M.J.
    • Journal: Mayo Clinic Proceedings
    • Volume: 98(6)
    • Pages: 949
    • Year: 2023
  7. Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationale
    • Authors: Joseph, J., Pajewski, N.M., Dolor, R.J., Shivaswamy, V., Ramalingam, R.
    • Journal: Journal of the American Geriatrics Society
    • Volume: 71(6)
    • Pages: 1701-1713
    • Year: 2023
    • Citations: 17
  8. New Drugs Approved in 2022
    • Authors: Ebied, A.M., Elmariah, H., Cooper-DeHoff, R.M.
    • Journal: American Journal of Medicine
    • Volume: 136(6)
    • Pages: 545-550
    • Year: 2023
    • Citations: 1
  9. Racial and Ethnic Differences in Cardiac Surveillance Evaluation of Patients Treated With Anthracycline-Based Chemotherapy
    • Authors: Deremer, D.L., Nguyen, N.K., Guha, A., Fradley, M.G., Gong, Y.
    • Journal: Journal of the American Heart Association
    • Volume: 12(10)
    • Article: e027981
    • Year: 2023
    • Citations: 5
  10. Disruption in Blood Pressure Control With the COVID-19 Pandemic: The PCORnet Blood Pressure Control Laboratory
    • Authors: Chamberlain, A.M., Cooper-DeHoff, R.M., Fontil, V., Knowlton, K.U., Pletcher, M.J.
    • Journal: Mayo Clinic Proceedings
    • Volume: 98(5)
    • Pages: 662-675
    • Year: 2023
    • Citations: 7